Colon Cancer Clinical Trial
Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management
Summary
This research project addresses critical gaps in cancer symptom management through the creation of a mobile chemotherapy symptom management application. This application will assess for the presence and severity of common chemotherapy side-effects and provide personally tailored symptom-related video and narratives to enhance self-management of cancer and treatment-related symptoms. This study will examine patient acceptance and use of this mHealth application (called MyChemoCare) in a prospective trial of cancer patients (n=60) who are receiving chemotherapy for colorectal cancer at the University of Michigan Comprehensive Cancer Center.
Eligibility Criteria
Inclusion Criteria:
Diagnosed with colon or rectal cancer
Expected to live at least 6 months
Initiating chemotherapy for the first time in their treatment history
Physically and mentally able to participate
Able to read English
Willing and able to sign informed consent
Exclusion Criteria:
A treatment plan that does not include cytotoxic chemotherapy for colon or rectal cancer
A medical history that includes cancer with the exception of in situ cancers of the cervix and basal cell cancers of the skin
A current diagnosis that includes multiple cancers (this does not exclude metastatic disease)
Received prior cytotoxic chemotherapy for any reason
A diagnosed psychiatric disorder
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Ann Arbor Michigan, 48109, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.